Nose-to-Brain Protein Delivery Shows Promise for Protecting Dopamine Neurons in Parkinson’s Models
A new study in BMC Medicine reports that intranasally delivered recombinant BMP2/6 proteins delayed dopaminergic neuron degeneration and improved motor function in mouse models of Parkinsonian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results